INTERNATIONAL PATENT: JANSSEN BIOTECH, INC. FILES APPLICATION FOR "METHODS FOR TREATING MULTIPLE MYELOMA COMPRISING AN ANTI-CD38 ANTIBODY COMBINED WITH BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE"

GENEVA, April 21 -- JANSSEN BIOTECH, INC. (800/850 Ridgeview DriveHorsham, Pennsylvania 19044) filed a patent application (PCT/US2024/050877) for "METHODS FOR TREATING MULTIPLE MYELOMA COMPRISING AN ANTI-CD38 ANTIBODY COMBINED WITH BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE" on Oct 11, 2024. With publication no. WO/2025/080911, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CARSON, Robin (851 Duportail RoadChesterbrook, Pennsylvania 19087), CHIU, Christopher (920 US Highway 202 SRaritan, New Jersey 08869), CRIST, Wendy (...